• Afatinib (SKU A4746): Reliable EGFR/HER2 Inhibition in Cance

  2026-08-04

  This authoritative guide addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays using Afatinib (SKU A4746). Supported by recent assembloid model evidence, it provides scenario-driven insights for selecting, optimizing, and interpreting results with this irreversible ErbB family tyrosine kinase inhibitor. Bench scientists gain practical value for experimental reproducibility and translational research.

• L-Phenylephrine: Selective α1A Adrenergic Agonist for Resear

  2026-08-04

  L-Phenylephrine is a selective adrenergic α1A receptor agonist widely used in cardiovascular and neurobiological research. Its high receptor specificity, ability to modulate gene expression, and reproducible physiological effects make it a benchmark tool for dissecting α1-adrenergic signaling pathways.

• (S)-(+)-Ibuprofen: Precision COX Inhibitor for Inflammation

  2026-08-03

  (S)-(+)-Ibuprofen (APExBIO, B1018) delivers robust, selective COX inhibition for high-fidelity inflammation and pain mechanism research. Explore protocol-ready guidance, troubleshooting insights, and practical workflow enhancements for both in vitro and in vivo applications.

• SLC2A5-Driven Fructose Metabolism in CNS Lymphoma: Single-Ce

  2026-08-03

  This study leverages single-cell multi-omics to reveal that SLC2A5-mediated fructose metabolism is a metabolic vulnerability in primary CNS lymphoma, shaped by hypoxia and low glucose in the tumor microenvironment. These findings offer new avenues for targeted therapy and provide a blueprint for dissecting tumor–microenvironment interactions in rare brain lymphomas.

• MLKL-Driven Lysosomal Permeabilization Orchestrates Necropto

  2026-08-02

  This study elucidates how MLKL polymerization at lysosomal membranes initiates membrane permeabilization, releasing cathepsins—especially cathepsin B—to execute necroptosis. These findings define a pivotal mechanistic link between lysosomal integrity and regulated necrotic cell death, offering new targets for intervention in inflammatory and degenerative diseases.

• Ordered DNA Frameworks Advance Enzymatic Oligonucleotide Syn

  2026-08-01

  A recent study introduces highly ordered tetrahedral DNA nanostructures (TDN) to improve the efficiency and fidelity of enzymatic oligonucleotide synthesis. This innovation significantly enhances enzyme accessibility and substrate affinity, enabling high-yield, low-error DNA synthesis, with important implications for DNA information storage and synthetic biology.

• NF-κB/Apaf1/Caspase-9 Axis in Septic AKI: Mechanistic Insigh

  2026-07-31

  This study establishes the NF-κB/Apaf1/caspase-9 axis as a central driver of tubular inflammation and apoptosis in septic acute kidney injury (AKI), acting through suppression of autophagy. The mechanistic dissection of this pathway provides a strong rationale for targeting upstream NF-κB signaling in inflammation research and highlights potential therapeutic strategies for sepsis-associated AKI.

• EZ Cap™ Human PTEN mRNA: Workflow Optimization in Tumor Stud

  2026-07-31

  EZ Cap™ Human PTEN mRNA enables robust, immune-evasive PTEN restoration for cancer and gene therapy research. Streamlined with Cap 1 and poly(A) tail modifications, it supports high-fidelity expression in both nanoparticle and conventional transfection workflows, empowering advanced studies of tumor suppressor gene function.

• DAF-2 Diacetate: Precision NO Imaging and Nodule Senescence

  2026-07-30

  Explore the science of DAF-2 diacetate for advanced nitric oxide imaging in live cells. This article uniquely connects probe biochemistry, legume nodule senescence, and assay optimization, offering actionable insights beyond standard protocols.

• 6-FAM SE: Advanced Fluorescent Labeling for Molecular Workfl

  2026-07-30

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) enables robust, hydrolysis-resistant fluorescent labeling of DNA, proteins, and peptides—delivering reliable sensitivity and stability in gene sequencing, molecular probe design, and nanoparticle-based assays. This article decodes cutting-edge experimental strategies, protocol optimizations, and troubleshooting tactics to maximize the utility of this amine-reactive dye across advanced molecular biology workflows.

• Mouse Tissue Lysis Kit (K1038): Practical Use and Workflow G

  2026-07-29

  The Mouse Tissue Lysis Kit (K1038) provides researchers with a rapid, simplified method for lysing mouse tissue samples to obtain DNA suitable for direct PCR-based genotyping, eliminating the need for conventional extraction and purification steps. This product is optimized for molecular biology research workflows but is not intended for diagnostic or medical applications.

• Otilonium Bromide: Next-Gen Antimuscarinic for Translational

  2026-07-29

  Explore the mechanistic depth and translational opportunity of Otilonium Bromide as a precision antimuscarinic agent. This article bridges receptor biology, experimental strategy, and clinical relevance, helping researchers advance reproducible, high-impact neuroscience and smooth muscle studies with APExBIO's flagship compound.

• Imipenem: Semisynthetic Thienamycin Antibiotic in Antibacter

  2026-07-28

  Imipenem is a semisynthetic thienamycin antibiotic with broad-spectrum activity against gram-negative and gram-positive bacteria. Its stability against beta-lactamases and high affinity for penicillin-binding proteins underpin its value in antibacterial research. Recent evidence highlights its role in resistance benchmarking and immune response modulation.

• Adenosine Triphosphate in Advanced Cellular Metabolism Resea

  2026-07-28

  Adenosine triphosphate (ATP) is vital not only as a universal energy carrier but also as a regulator and signaling molecule in metabolic research. This article translates the latest breakthroughs—including TCAIM-mediated mitochondrial enzyme control—into actionable workflows, protocol enhancements, and troubleshooting strategies for robust, reproducible results using APExBIO's high-purity ATP.

• Foretinib (GSK1363089): Precision Metrics in Cancer Drug Res

  2026-07-27

  Explore how Foretinib (GSK1363089) enables precise tumor cell growth inhibition assessment using advanced viability metrics. This article reveals deeper assay strategies and practical implications for translational cancer research.

16345 records 1/1090 page Next 12345 下5页 Last page